RASAL1 and colonic neoplasm: After RASAL1 transfection for 24 h, the percentage of colon cancer cells in the G2/M phase increased (LoVo: 9.4–21.7%; HCT-116: 11.7–20.4%) compared to the control (Fig. 2c, d).